(Press-News.org) Acting as a team, twin stem cells activate the immune system to suppress tumor growth and prolong survival in representative preclinical models
Overall survival for patients with melanoma that has spread to the brain is only four to six months. Immunotherapies, which harness the power of the immune system to attack cancer cells, have garnered excitement in recent years for their potential to revolutionize the treatment of metastatic melanomas, but results from early clinical studies indicate that the prognosis for most patients remains poor. Now, scientists from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have integrated multiple therapeutic approaches to more effectively target melanoma in the brain. In preclinical studies, the scientists successfully activated immune responses in sophisticated mouse models that mimic human settings. Findings are published in Science Translational Medicine.
“We know that in advanced cancer patients with brain metastases, systemic drugs, given intravenously and orally, do not effectively target brain metastases,” said corresponding author Khalid Shah, MS, PhD, director of the Center for Stem Cell and Translational Immunotherapy (CSTI) and the vice chair of research in the Department of Neurosurgery at the Brigham and faculty at Harvard Medical School and Harvard Stem Cell Institute (HSCI). “We have now developed a new immuno-therapeutic approach that is sustainable and delivered locally to the tumor. We believe that locally delivered immunotherapies represent the future of how we will be treating metastases to the brain.”
The therapy designed by the scientists uses an engineered “twin stem cell model” to maximize an attack on cancer cells that have spread to a part of the brain known as the leptomeninges. One stem cell releases a cancer-killing (oncolytic) virus, a strategy that has previously shown promise in reducing tumor growth. Using stem cells to deliver the virus amplifies the amount of virus that can be released and ensures that the virus will not be degraded by circulating antibodies before it is released on the cancer cells.
However, the oncolytic virus also destroys the very cells that release it, making it an unsustainable therapeutic option on its own. Therefore, the scientists used CRISPR/Cas9 gene editing to a create a second stem cell that cannot be targeted by the oncolytic virus, and which instead releases proteins (immunomodulators) that fortify the immune system to help fight off the cancer.
The twin stem cells can be delivered via intrathecal injection, a technique already used in the treatment of other diseases. Unlike other immunotherapies that have emerged in recent years, it does not need to be repeatedly administered. The authors emphasize that this approach can be used in other cancers with brain metastasis, such as lung and breast cancer, and are working to design similar treatments for these cancers.
Notably, the authors were able to design a preclinical mouse model that faithfully represents a human model of melanoma with leptomeningeal metastasis, which they used to test their therapy. They found that the therapy successfully activated immune responses in their models that mimic human responses, improving the likelihood that the therapy may succeed in a Phase I trial, which the authors are hoping to launch in the near future.
“A number of biological therapies that look promising often fail in Phase I or Phase II clinical trials, in part because the preclinical models do not authentically replicate clinical settings,” Shah said. “We realized that if we did not fix this piece of the puzzle, we would always be playing catch-up. I don’t think we have been at a point in the last 20 years where we have been as close to curing metastases in the brain as we are now.”
Disclosures: Shah owns equity in and is a member of the Board of Directors of AMASA Therapeutics, a company developing stem cell-based therapies for cancer. The patent application entitled “Gene editing and engineering stem cell for drug delivery” (PCT/US22/49523) has been filed. A full list of disclosures is published in the paper.
Funding: This study was mainly supported by the U.S. Department of Defense. A complete list of funding sources is published in the paper.
Paper cited: Kanaya, N, et al. “Gene edited and engineered stem cell platform drives immunotherapy for brain metastatic melanomas” Science Translational Medicine DOI: 10.1126/scitranslmed.ade8732
END
Gene engineered cell therapy developed to target brain metastatic melanomas
Acting as a team, twin stem cells activate the immune system to suppress tumor growth and prolong survival in representative preclinical models
2023-05-31
ELSE PRESS RELEASES FROM THIS DATE:
Ground beneath Thwaites Glacier mapped for first time
2023-05-31
Embargoed until Wednesday 31 May at 2.00pm EST // 7.00pm UK BST
The ground beneath Antarctica’s most vulnerable glacier has been mapped for the first time, helping scientists to better understand how it is being affected by climate change. Analysis of the geology below the Thwaites Glacier in West Antarctica shows there is less sedimentary rock than expected – a finding that could affect how the ice slides and melts in the coming decades.
“Sediments allow faster flow, like sliding on mud,” says Dr Tom Jordan, a geophysicist with the British ...
New Penn Medicine study uncovers key details of fat cells, advancing potential treatments for obesity, diabetes
2023-05-31
PHILADELPHIA—New research has unlocked insights into how “good fat” tissue could potentially be harnessed to combat obesity and remove glucose from the blood, helping to control diabetes. Published today in Science Advances, the work is a collaboration between researchers with the Perelman School of Medicine at the University of Pennsylvania and University of Cambridge, Free University of Brussels and University of East Anglia.
Human bodies consist of two types of fat: brown and white. Brown fat breaks down blood sugar (glucose) and fat molecules, generating heat in response to ...
Study shines light on cause of chronic kidney disease
2023-05-31
Fresh insights into a protein that causes damage in kidneys and hearts could open up new treatment options for chronic kidney disease, research shows.
In a study in mice, scientists found that scarring in kidneys and hearts was driven by a protein called Indian Hedgehog (IHH), which is produced and released by a subset of cells in aged and injured kidneys.
Experts say further studies are needed to explore IHH as a potential target for therapies to treat chronic kidney disease (CKD) – a condition that affects 10 per cent of the world’s ...
The breakthrough that could lead to new obesity treatments
2023-05-31
Researchers at the University of East Anglia and the University of Cambridge have made an important discovery in the race to find treatments for obesity and related diseases, such as diabetes.
A new study published today is the first to reveal the molecular structure of a protein called ‘Uncoupling protein 1’ (UCP1).
This protein allows brown fat tissue, or ‘good fat’, to burn off calories as heat - in contrast to conventional white fat that stores calories.
The breakthrough was made by an international collaboration between UEA, the University of Cambridge, ...
Cutting breakfast carbs can benefit people with Type 2 diabetes
2023-05-31
An international team, led by UBC Okanagan researchers, suggests a simple tweak to the first meal of the day might help people living with Type 2 diabetes (T2D) better control their blood sugar levels.
Dr. Barbara Oliveira conducts research with Dr. Jonathan Little’s Exercise, Metabolism and Inflammation Lab in UBCO’s Faculty of Health and Social Development. Their latest study, published this week in the American Journal of Clinical Nutrition, confirms that switching from a traditional western-style low-fat breakfast, like oatmeal, toast and fruit, to a low-carb meal higher in ...
Targeting Phage Therapy World Conference 2023: 73 communications will be presented this week in Paris, France
2023-05-31
The 6th World Conference on Targeting Phage Therapy 2023 which will be held in Paris on June 1-2 will welcome more than 70 communications (major, short and poster presentations), and gather more than 150 international in-person and virtual participants from 31 countries.
Targeting Phage Therapy 2023: Strategic Questions
Phage Therapy 2023’s aim is to present the most recent advances on phage therapy within different sessions and topics. Each speaker will highlight where we are now and where we are heading. We believe that phages will be the hottest topic not only to combat infection and antibiotic resistance, ...
Special Issue of Health Equity devoted to veterans issues
2023-05-31
A special issue of the peer-reviewed journal Health Equity titled “Improving Care for Veterans Through Health Equity Research" includes 13 articles that discuss issues vital to Veterans. These articles range from highlighting the importance of expanding the scientific workforce to promoting health equity within the Veterans Administration. Click here to read the issue now.
Rachel Ramoni and Carolyn Clancy, from the Department of Veterans Affairs, coauthored the article titled “Improving Care for Veterans Through Health Equity Research.” To improve Veterans’ well-being, “we must actively ...
Crossing the ring: new method enables C-H activation across saturated carbocycles
2023-05-31
LA JOLLA, CA— A new “molecular editing” technique from Scripps Research enables chemists to add new elements to organic molecules at locations that were previously out of reach.
The researchers described their new method in a paper that appeared on May 31, 2023, in Nature. The method uses a designer molecule called a ligand that helps a palladium-atom catalyst reach from one side of a carbon-atom ring to break a carbon-hydrogen bond on the other side, allowing a new set of molecules to join at that site. This molecule-building feat was previously impossible for so-called “saturated” rings of carbon atoms, which are common ...
How much nitrogen does corn get from fertilizer? Less than farmers think
2023-05-31
URBANA, Ill. — Corn growers seeking to increase the amount of nitrogen taken up by their crop can adjust many aspects of fertilizer application, but recent studies from the University of Illinois Urbana-Champaign show those tweaks don’t do much to improve uptake efficiency from fertilizer. That’s because, the studies show, corn takes up the majority of its nitrogen – about 67% on average – from sources occurring naturally in soil, not from fertilizer.
The evidence for ...
UC Irvine-led study finds Medicaid telemedicine coverage boosted use, healthcare access
2023-05-31
Irvine, Calif., May 31, 2023 – Medicaid telemedicine coverage between 2013 and 2019 was associated with significant growth in telemedicine use and improved healthcare access, while private policies did not have such an association, according to a study led by the University of California, Irvine.
An analysis of 20,000 records of U.S. adults under 65 with either state-level Medicaid or private policies showed that live video chats increased by 6 percentage points and that the ability to consistently access necessary care increased by 11 percentage points for Medicaid patients.
Recently ...
LAST 30 PRESS RELEASES:
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
Association of state cannabis legalization with cannabis use disorder and cannabis poisoning
Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders
Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals
Unlocking the mysteries of the human gut
High-quality nanodiamonds for bioimaging and quantum sensing applications
New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
Evolution of fast-growing fish-eating herring in the Baltic Sea
Cryptographic protocol enables secure data sharing in the floating wind energy sector
Can drinking coffee or tea help prevent head and neck cancer?
Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration
Scientists unlock secrets behind flowering of the king of fruits
Texas A&M researchers illuminate the mysteries of icy ocean worlds
Prosthetic material could help reduce infections from intravenous catheters
[Press-News.org] Gene engineered cell therapy developed to target brain metastatic melanomasActing as a team, twin stem cells activate the immune system to suppress tumor growth and prolong survival in representative preclinical models